Medincell (MEDCL)

Price€22.80Cached quoteAs of 2026-09-05 19:06 UTC

Loading local price history

Total cash / debt

CashTotal debt

2021

2022

2023

2024

2025

2026

Financial statements

	2026	2025	2024	2023	2022	2021
Revenue	€24.3M	€27.7M	€11.9M	€13.7M	€8.3M	€11.8M
Gross profit	€24.3M	€27.7M	€11.9M	€13.7M	€8.3M	€11.8M
Gross margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Research & development	€26.5M	€24.3M	€21.1M	€27.9M	€23.6M	€19.5M
Operating expenses	€45.0M	€38.5M	€32.9M	€37.7M	€32.2M	€27.4M
Operating income	−€20.8M	−€10.8M	−€21.0M	−€24.0M	−€23.8M	−€15.6M
Operating margin	−85.60%	−39.10%	−175.61%	−176.10%	−285.61%	−132.28%
EBITDA	−€19.0M	−€8.8M	−€19.3M	−€22.4M	−€22.3M	−€14.2M
EBITDA margin	−78.09%	−31.92%	−161.22%	−163.90%	−267.43%	−120.91%
Net income	−€31.3M	−€18.4M	−€25.0M	−€32.0M	−€24.8M	−€19.0M
Net profit margin	−128.88%	−66.50%	−209.61%	−234.42%	−297.51%	−161.24%
Basic EPSper basic share	-€0.94	-€0.62	-€0.88	-€1.27	-€1.00	-€0.86
Diluted EPSper diluted share	-€0.94	-€0.62	-€0.88	-€1.27	-€1.00	-€0.86

Review official source filings ↗

Owners

Reported shareholders and owner groups

Source dated Oct 15, 2026

17.00%of company shares

ConsultantsSource updated Oct 15, 2026

View holders

Reported shareholders of MEDCL
Holder	Ownership
Consultants	17.00%Oct 15, 2026
Mirova	6.20%Oct 15, 2026
Employees	6.00%Oct 15, 2026
Polar Capital LLP	6.00%Oct 15, 2026
Groupe Industriel Marcel Dassault	5.20%Oct 15, 2026
Anh Nguyen	3.60%Oct 15, 2026
Syquant Capital	3.20%Oct 15, 2026
BNP Paribas Développement SA	3.00%Oct 15, 2026
CDC Croissance	3.00%Oct 15, 2026
Members of the board	2.20%Oct 15, 2026

These Euronext company-profile figures report shares in the company's capital. Named holders and owner groups are shown as published; free float, treasury shares, and unspecified holders are excluded from the colored segments.

Gray completes the 100% scale; it is not an estimate of other owners.

Source: Euronext / Cofisem ↗Checked Oct 21, 2026